Prevent Problems With the New, Injectable Aimovig for Migraine Prevention

You'll hear buzz about Aimovig (AIM-oh-vig, erenumab), a new, injectable biologic to PREVENT migraine in adults.

Expect Aimovig to be saved for when patients don't respond to, or can't tolerate, first-line meds for preventing migraine...such as beta-blockers (propranolol, etc), topiramate, or valproate.

Aimovig blocks the calcitonin gene-related peptide (CGRP) receptor...to help decrease migraine attacks. Expect more of these "CGRP antagonists" to be approved within a few months.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote